• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 Eurotransplant Senior Kidney Transplant Program 中,70 岁以上的肾移植受者的长期预后:单中心经验。

Long-term outcome in kidney transplant recipients over 70 years in the Eurotransplant Senior Kidney Transplant Program: a single center experience.

机构信息

Department of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Innsbruck Medical University, Innsbruck, Austria.

出版信息

Transplantation. 2011 Jul 27;92(2):210-6. doi: 10.1097/TP.0b013e318222ca2f.

DOI:10.1097/TP.0b013e318222ca2f
PMID:21642907
Abstract

BACKGROUND

Kidney transplantation in the elderly is complicated by comorbidities and a higher incidence of death. The Eurotransplant Senior Program (ESP) has been established to allocate kidneys from older donors to the increasing number of older recipients. In this retrospective, single center data analysis, we compare the outcome of recipients older than 70 years with younger recipients transplanted under the ESP protocol.

METHODS

Between 1999 and 2009, a total of 83 kidneys were transplanted under the ESP protocol in Innsbruck and 19 of the recipients were older than 70 years (mean, 72.7 years). Cold ischemia time was kept short in both groups by giving preference to regional donor organs.

RESULTS

Patient survival at 1 and 5 years were 95% and 67% in the 70+ group and 94.4% and 82.6% in the 70- group. Graft survival was 95% and 52% at 1 and 5 years in the 70+ group and 94.4% and 79.0% in the 70- group. When censored for death, graft survival at year 1 and 5 were 100% and 82% in the 70+ group and 98.1% and 92.7% in the 70- group. The delayed graft function rate was high in both groups (36.8% and 41.1%, respectively). Morbidities were largely related to hemodynamic, oncologic, and infectious events. Cardiac failure was the major cause of death.

CONCLUSION

Relatively good results can be achieved with renal transplantation in patients older than 70 years under careful pretransplant evaluation and postoperative management of comorbidities.

摘要

背景

老年人进行肾移植会受到合并症的影响,且死亡率较高。欧洲肾脏移植协会老年项目(ESP)旨在将来自老年供体的肾脏分配给越来越多的老年受者。在这项回顾性、单中心数据分析中,我们比较了在 ESP 方案下接受移植的 70 岁以上老年受者与年龄较小受者的结局。

方法

1999 年至 2009 年,因 ESP 方案在因斯布鲁克共进行了 83 例肾移植,其中 19 例受者年龄大于 70 岁(平均年龄 72.7 岁)。两组均通过优先使用区域性供体器官,将冷缺血时间保持在较短的范围内。

结果

70 岁以上组患者 1 年和 5 年的存活率分别为 95%和 67%,70 岁以下组分别为 94.4%和 82.6%。70 岁以上组 1 年和 5 年的移植物存活率分别为 95%和 52%,70 岁以下组分别为 94.4%和 79.0%。当因死亡而被删失时,70 岁以上组患者 1 年和 5 年的移植物存活率分别为 100%和 82%,70 岁以下组分别为 98.1%和 92.7%。两组的延迟肾功能恢复率均较高(分别为 36.8%和 41.1%)。发病主要与血流动力学、肿瘤和感染事件有关。心力衰竭是主要的死亡原因。

结论

在进行仔细的移植前评估和术后合并症管理的情况下,70 岁以上患者接受肾移植可获得相对较好的结果。

相似文献

1
Long-term outcome in kidney transplant recipients over 70 years in the Eurotransplant Senior Kidney Transplant Program: a single center experience.在 Eurotransplant Senior Kidney Transplant Program 中,70 岁以上的肾移植受者的长期预后:单中心经验。
Transplantation. 2011 Jul 27;92(2):210-6. doi: 10.1097/TP.0b013e318222ca2f.
2
Renal transplantation in the elderly: surgical complications and outcome with special emphasis on the Eurotransplant Senior Programme.老年人肾移植:手术并发症及结局,特别关注欧洲移植老年项目
Nephrol Dial Transplant. 2008 Jun;23(6):2043-51. doi: 10.1093/ndt/gfm912. Epub 2008 Jan 18.
3
Long-term outcomes of kidney transplantation in recipients 60 years of age and older at the University of Florida.佛罗里达大学60岁及以上肾移植受者的长期预后
Clin Transpl. 2005:101-9.
4
Patient and graft outcomes from deceased kidney donors age 70 years and older: an analysis of the Organ Procurement Transplant Network/United Network of Organ Sharing database.70岁及以上已故肾脏供体的患者和移植物结局:器官获取与移植网络/器官共享联合网络数据库分析
Transplantation. 2008 Jun 15;85(11):1573-9. doi: 10.1097/TP.0b013e31817059a1.
5
The UNOS renal transplant registry.美国器官共享联合网络肾脏移植登记处。
Clin Transpl. 2001:1-18.
6
The LifeLink Foundation and cadaver kidney transplantation in Tampa.生命链接基金会与坦帕的尸体肾移植
Clin Transpl. 1999:149-58.
7
Kidney transplantation at the Charité: long tradition, elderly patients and the duration of hospitalization.柏林夏里特医院的肾移植:悠久传统、老年患者与住院时长
Clin Transpl. 2002:171-9.
8
Outcomes of kidney transplantation from older living donors to older recipients.老年活体供者向老年受者进行肾移植的结果。
Am J Kidney Dis. 2008 Sep;52(3):541-52. doi: 10.1053/j.ajkd.2008.05.017. Epub 2008 Jul 24.
9
A multi-factor analysis of kidney graft outcomes at one and five years posttransplantation: 1996 UNOS Update.肾移植术后1年和5年移植肾结局的多因素分析:1996年器官共享联合网络更新版
Clin Transpl. 1996:343-60.
10
A multi-factor analysis of kidney regraft outcomes.肾脏再次移植结果的多因素分析。
Clin Transpl. 2002:335-49.

引用本文的文献

1
Clinical and Histopathological Determinants for Kidney Allograft Survival in the Eurotransplant Senior Program (ESP) at the Time of Allocation.欧洲移植高级计划(ESP)分配时肾移植受者存活的临床和组织病理学决定因素
Transpl Int. 2025 Jun 2;38:14153. doi: 10.3389/ti.2025.14153. eCollection 2025.
2
and gene polymorphisms influence graft survival, and response to therapy in kidney transplantation.并且基因多态性影响肾移植中的移植物存活率和对治疗的反应。
Front Immunol. 2024 Nov 7;15:1440887. doi: 10.3389/fimmu.2024.1440887. eCollection 2024.
3
Old Age and Frailty in Deceased Organ Transplantation and Allocation-A Plea for Geriatric Assessment and Prehabilitation.
老年和虚弱与器官移植和分配-老年评估和预康复的呼吁。
Transpl Int. 2023 Jul 5;36:11296. doi: 10.3389/ti.2023.11296. eCollection 2023.
4
Kidney Transplant Outcomes in Elderly Population: A Systematic Review and Meta-analysis.老年人群肾移植结果:系统评价与荟萃分析
Eur Urol Open Sci. 2023 Mar 22;51:13-25. doi: 10.1016/j.euros.2023.02.011. eCollection 2023 May.
5
Kidney Transplant Outcomes in Recipients Over the Age of 70.70岁以上肾移植受者的肾移植结果
Cureus. 2023 Jan 20;15(1):e34021. doi: 10.7759/cureus.34021. eCollection 2023 Jan.
6
Outcomes of Deceased Donor Kidney Transplantation in the Eurotransplant Senior Program with A Focus on Recipients ≥75 Years.欧洲移植高级项目中已故供体肾移植的结果,重点关注75岁及以上的受者。
J Clin Med. 2021 Nov 29;10(23):5633. doi: 10.3390/jcm10235633.
7
Pharmacokinetic and Pharmacodynamic Considerations in Relation to Calcineurin Usage in Elderly Kidney Transplant Recipients.老年肾移植受者使用钙调神经磷酸酶抑制剂的药代动力学和药效学考量
Front Pharmacol. 2021 Apr 12;12:635165. doi: 10.3389/fphar.2021.635165. eCollection 2021.
8
Two decades of the Eurotransplant Senior Program: the gender gap in mortality impacts patient survival after kidney transplantation.欧洲移植高级项目二十年:死亡率方面的性别差异对肾移植术后患者生存的影响
Clin Kidney J. 2019 Sep 16;13(6):1091-1100. doi: 10.1093/ckj/sfz118. eCollection 2020 Dec.
9
Should We Perform Old-for-Old Kidney Transplantation during the COVID-19 Pandemic? The Risk for Post-Operative Intensive Stay.在新冠疫情期间我们应该进行老年供老年肾移植吗?术后重症监护停留的风险。
J Clin Med. 2020 Jun 12;9(6):1835. doi: 10.3390/jcm9061835.
10
Characterizing the pharmacokinetics and pharmacodynamics of immunosuppressant medicines and patient outcomes in elderly renal transplant patients.描述老年肾移植患者免疫抑制药物的药代动力学和药效学以及患者预后。
Transl Androl Urol. 2019 May;8(Suppl 2):S198-S213. doi: 10.21037/tau.2018.10.16.